Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia
EJHaem
.
2023 Apr 1;4(2):499-500.
doi: 10.1002/jha2.686.
eCollection 2023 May.
Authors
Haya Jamali
1
,
David Wu
2
,
Lorinda Soma
3
,
Michael Linenberger
4
,
Mark H Wener
2
5
,
Lev Silberstein
6
Affiliations
1
Department of Medicine Massachusetts General Hospital Boston Massachusetts USA.
2
Department of Laboratory Medicine and Pathology Seattle Washington USA.
3
Department of Pathology City of Hope Medical Center Duarte California USA.
4
Division of Hematology University of Washington Seattle Washington USA.
5
Division of Rheumatology University of Washington Seattle Washington USA.
6
Fred Hutchinson Cancer Center Seattle Washington USA.
PMID:
37206249
PMCID:
PMC10188461
DOI:
10.1002/jha2.686
No abstract available
Keywords:
Waldenstrom macroglobulinemia; cryoglobulinemia; ibrutinib.